EpiCast Report: Endometriosis – Epidemiology Forecast to 2022

Publisher Name :
Date:25-Sep-2013
No. of pages: 38

Endometriosis is an estrogen-dependent disorder characterized by growth and appearance of endometrial cells or tissues in locations outside the uterus, which results in a series of chronic inflammatory reactions leading to scarring of tissues and adhesions of fibrous tissues in the pelvic region. Globally, the disease affects up to 10% of women. The condition is often associated with severe dysmenorrhea, chronic pelvic pain, chronic fatigue, deep dyspareunia, ovulation pain, abnormal bleeding and infertility.

The report provides an overview of the risk factors and global and historical trends for endometriosis in the 6MM. In addition, the report also includes a 10-year epidemiological forecast of the diagnosed prevalent cases of endometriosis segmented by age (in 5-year increments for women ages 15-49 years) and stages. GlobalData epidemiologists forecast that the diagnosed prevalent cases of endometriosis in the 6MM will grow from 5.66 million cases in 2012 to 5.86 million cases in 2022, at a growth rate of 3.4% over the forecast period.

GlobalData epidemiologists forecast an increase in the diagnosed prevalent cases of endometriosis in the 6MM, from 5.66 million prevalent cases in 2012 to 5.86 million prevalent case in 2022, at a growth rate of 3.4% over the forecast period. The US constituted the largest proportion (almost 90%) of the prevalent cases of endometriosis, with 5.24 million prevalent cases in 2022. Endometriosis is not a life-threatening condition and is largely influenced by hereditary factors. However, the condition will cause substantial economic, physical and psycho-social burden to the individual, as well as to the healthcare system, during the forecast period.

Scope

  • The Endometriosis EpiCast Report provides an overview of the risk factors and global trends of endometriosis in the 6MM (US, France, Germany, Italy, Spain, and UK). It includes a 10-year epidemiology forecast of the diagnosed prevalent cases of endometriosis segmented by age (in 5-year increments for women ages 15-49 years) and stages.
  • The endometriosis epidemiology report is written and developed by Mastersand PhD-level epidemiologists.
  • The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 6MM.

Reasons to buy

  • Develop business strategies by understanding the trends shaping and driving the global endometriosis market.
  • Quantify patient populations in the global endometriosis market to improve product design, pricing, and launch plans.
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for endometriosis therapeutics in each of the markets covered.

EpiCast Report: Endometriosis – Epidemiology Forecast to 2022

Table of Contents

1 Table of Contents 4
1.1 List of Tables 5
1.2 List of Figures 5

2 Introduction 6
2.1 Catalyst 6

3 Epidemiology 7
3.1 Disease Background 7
3.2 Risk Factors and Comorbidities 9
3.2.1 Family history is a strong predictor for the risk of endometriosis 10
3.2.2 Late age at menarche protects women from developing endometriosis 11
3.2.3 Higher parity decreases the risk for endometriosis 12
3.3 Global Trends 13
3.3.1 US 14
3.3.2 5EU 15
3.4 Forecast Methodology 16
3.4.1 Sources Used 17
3.4.2 Sources Not Used 19
3.4.3 Forecast Assumptions and Methods 20
3.5 Epidemiological Forecast of Endometriosis (2012-2022) 22
3.5.1 Diagnosed Prevalent Cases of Endometriosis 22
3.5.2 Age-Specific Prevalent Cases of Endometriosis 23
3.5.3 Age-Standardized Prevalence of Endometriosis 25
3.5.4 Diagnosed Prevalent Cases of Endometriosis by Stage 26
3.6 Discussion 27
3.6.1 Epidemiological Forecast Insight 27
3.6.2 Limitations of the Analysis 28
3.6.3 Strengths of the Analysis 30

4 Appendix 31
4.1 Bibliography 31
4.2 About the Authors 34
4.2.1 Epidemiologists 34
4.2.2 Reviewers 34
4.2.3 Global Director of Epidemiology and Health Policy 36
4.2.4 Global Head of Healthcare 36
4.3 About GlobalData 37
4.4 About EpiCast 37
4.5 Disclaimer 37

List of Tables

Table 1: Stages of Endometriosis (as per American Society of Reproductive Medicine) 8
Table 2: Risk Factors for Endometriosis 9
Table 3: Epidemiological Sources for Diagnosed Prevalence and Stages of Endometriosis 16
Table 4: 6MM, Diagnosed Prevalent Cases of Endometriosis, Ages 15-49 Years, N, 2012-2022 22
Table 5: 6MM, Prevalent Cases of Diagnosed Endometriosis, by Age, N, Row (%), 2012 24
Table 6: 6MM, Prevalent Cases of Diagnosed Endometriosis by Stages, Ages 15-49 Years, N, Row (%), 2012 26

List of Figures

Figure 1: 6MM, Diagnosed Prevalent Cases of Endometriosis, Ages 15-49 Years, N, 2012-2022 23
Figure 2: 6MM, Prevalent Cases of Diagnosed Endometriosis, by Age, N, 2012 24
Figure 3: 6MM, Age-Standardized Prevalence (%) of Diagnosed Endometriosis, Ages 15-49 Years, 2012 25
Figure 4: 6MM, Prevalent Cases of Diagnosed Endometriosis by Stage, Ages 15-49 Years, 2012 27

  • Challenges in the Tourism Industry in Thailand
    Thailand has always been a popular tourist destination and tourism provides a major boost to the country’s economy. Bangkok, Hua Hin, Krabi, Samui, Phuket and Cha Am are some of the most attractive tourist destinations in the country. In 2012, Thailand had a very high number of arrivals. Even the number of Thai citizens who [...]
  • Future of the US Consumer Electronics Market
    The market for consumer electronics has been growing steadily. Some of the factors that are contributing to the growth in the market are technological advancement, rise in disposable income and increasing demand for new products. During 2012, consumer electronics market in the US demonstrated positive expansion, although the growth rate slowed down considerably following the [...]
  • Overview of the Global Retail Market
    The global retail industry continued to grow despite the difficult economic conditions in the world. In the fiscal year of 2011, sales-weighted, currency-adjusted revenue rose by 5.1% to $4.271 trillion for the world’s top 250 retailers. According to GRDI (Global Retail Development Index), in 2013 Brazil occupied the top spot in retail development. Chile and [...]
  • Bright Future Predicted for the Tourism Industry in Singapore
    Travel and tourism industry in Singapore has been growing at a steady rate and is considered to be a major contributor to the economic growth of the country. In 2012, Singapore’s IVA (International Visitors Arrivals) reached a record high of 14.5 million, with a growth rate of 10.1% year-on-year. In recent years, inbound travel to [...]
  • Potential of Staffing Market in United States
    The staffing industry places individuals into contract, temporary and permanent positions in firms around the world. Major staffing markets include France, Spain, Italy and Japan as well as many emerging markets. Temporary staffing around the world has been growing, but in US temporary market has been flat since 2006. The majority of staffing revenue majorly [...]
  • Graft-Versus-Host Disease (GVHD) Treatment Market worth $407 million by 2018
  • The graft-versus-host disease (GVHD) treatment market value will increase from $297 million in 2013 to $407 million by 2018, at a Compound Annual Growth Rate (CAGR) of 6.59%, according to research and consulting firm GlobalData. The company’s latest report* states …

  • Poland Pharmaceutical Industry Growing at 8.3% CAGR to 2020
  • Factors such as the growing elderly population, increasing availability of affordable medicines, and transparent regulatory guidelines will provide the necessary impetus for the growth of the Polish pharmaceutical market, but a decrease in mark-up prices and the country’s stringent drug …

  • Asia-Pacific, Led by China, Drive the Global Methanol Industry
  • China is driving the global methanol industry, with tremendous demand from both its energy and petrochemicals sectors. It accounts for 87.9% of Asia-Pacific’s (APAC) methanol capacity, and 51.9% of the global methanol capacity. Despite a large planned capacity increase in …

  • Diagnostic X-ray Imaging Market worth $4.0 billion by 2020
  • GlobalData estimates that the global diagnostic X-ray imaging market, worth $2.4 billion in 2012, will reach almost $4.0 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. Many players are active in …

  • Graft-Versus-Host Disease Market Forecast to 2023
  • Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either …

  • OpportunityAnalyzer: Graft-Versus-Host Disease – Opportunity Analysis and Forecasts to 2018
    Published: 21-Aug-2014        Price: US $5995 Onwards        Pages: 253
    The main drivers of growth in graft versus host disease over the 2013-2018 forecast period include the increasing numbers of allogeneic hematopoietic stem cell transplants and the increasing use of biologic off-label and marketed therapies in the 6MM.Sanofi is a key player in the GVHD market with Thymoglobuline and Lemtrada by infiltrating prophylaxis, aGVHD and cGVHD. J&J’s Remicade, has gained a significant patent share of the aGVHD patient group, as it is one of the few drugs that a......
  • Global Heart Valve Repair and Replacement Market 2014-2018
    Published: 20-Aug-2014        Price: US $2500 Onwards        Pages: 78
    About Heart Valve Repair and Replacement Heart valves are structures in the human heart which control the flow of blood during the cardiac cycle. A person affected with heart valve diseases such as valvular stenosis, valvular insufficiency or regurgitation, prolapse, and atresia requires the repair or replacement of the natural heart valves. Aortic valves cannot be repaired; therefore, it is replaced using prosthetic heart valves. However, the mitral, tricuspid, and pulmonary valves can be repa......
  • Croatia Pharmaceuticals and Healthcare Report Q4 2014
    Published: 20-Aug-2014        Price: US $1295 Onwards        Pages: 102
    BMI View: Heavy price cuts and margin restrictions within the pharmaceutical supply chain threaten to cause drug shortages and weaken the supply chain within Croatia, with product withdrawals expected and the HZZO braced for revolt from pharmacies and wholesalers. We forecast weak pharmaceutical market growth over the next decade, in light of Croatia's acceding to EU pressure to rein in its budget deficit. Liquidity issues and payment terms will remain unfavourable in 2014, but with Croatia's ec......
  • Global Meningococcal Vaccines Market 2014-2018
    Published: 20-Aug-2014        Price: US $2500 Onwards        Pages: 78
    About Meningococcal Vaccines Meningitis is characterized by the inflammation of the protective lining (meninges) present around the brain and the spinal cord. On the basis of its underlying cause, meningitis can be classified into infectious and non-infectious meningitis. In terms of the type of organism, infectious meningitis can be sub-divided into bacterial meningitis, viral meningitis, fungal meningitis, and parasitic meningitis. Bacterial meningitis is the life-threatening form of infectiou......
  • Kenya Pharmaceuticals and Healthcare Report Q4 2014
    Published: 20-Aug-2014        Price: US $1295 Onwards        Pages: 106
    BMI View: Investment into Kenya's healthcare sector by pharmaceutical and medical device companies is an advisable business strategy - as highlighted by the high growth forecast in healthcare spending between 2013 and 2018. However, we note that there are downside risks to our forecast, including government inefficiencies and the out-of-pocket characteristics of the market, which will act as challenges for companies looking for a rapid return on investment. Headline Expenditure Projections ? Pha......
  • Global Biodegradable Packaging Materials Market 2014-2018
    Published: 20-Aug-2014        Price: US $3000 Onwards        Pages: 100
    About Biodegradable Packaging Materials Biodegradable materials are materials that are readily decomposed by the action of microorganisms. Biodegradable packaging differs from conventional non-degradable packaging in terms of raw materials, production technology, applications, and composting. Biodegradable materials such as bio-plastic and paper are widely used in packaging applications because of their sustainable nature, material properties, and appearance. Biodegradable packaging materials ar......
  • Latvia Pharmaceuticals and Healthcare Report Q4 2014
    Published: 20-Aug-2014        Price: US $1295 Onwards        Pages: 107
    BMI View: Latvia's macroeconomic environment continues to improve at the same time as smooth transitions to a new currency and new Prime Minister. Market growth forecasts are strong although the country will continue to present a modest opportunity to larger multinational companies on account of its relatively small market size. Meanwhile, tensions between Ukraine and Russia may provide challenges for local manufacturers looking towards exports to Russia to boost revenue. Headline Expenditure Pr......
  • Global Multiple Sclerosis Drugs Market 2014-2018
    Published: 20-Aug-2014        Price: US $3000 Onwards        Pages: 102
    About Multiple Sclerosis and Disease Types Multiple sclerosis is a chronic, inflammatory medical condition that results in demyelination, axonal transection, and neurodegeneration. The myelin sheath is damaged because of an abnormal response by the immune system, which targets neurons within the central nervous system (CNS). It is a potentially debilitating disease in which the damage of the myelin sheath causes disruption in the communication and coordination functions of the body. The symptoms......
  • Mexico Pharmaceuticals and Healthcare Report Q4 2014
    Published: 20-Aug-2014        Price: US $1295 Onwards        Pages: 144
    BMI View: The lack of a unified reimbursement system, the absence of widespread private health insurance, relatively low healthcare spending and the promotion of generic drugs in Mexico will continue to undermine revenue-generating opportunities for innovative drugmakers. However, over the long term, healthier fiscal revenue due to energy reform will encourage the Mexican government to further increase public spending on medical services and improve national healthcare standards.. Headline Expen......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs